BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang X, Chen Y, Fan Y. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma. Environ Sci Pollut Res Int 2021. [PMID: 34775559 DOI: 10.1007/s11356-021-17321-9] [Reference Citation Analysis]
2 Synowiec A, Jedrysik M, Branicki W, Klajmon A, Lei J, Owczarek K, Suo C, Szczepanski A, Wang J, Zhang P, Labaj PP, Pyrc K. Identification of Cellular Factors Required for SARS-CoV-2 Replication. Cells 2021;10:3159. [PMID: 34831382 DOI: 10.3390/cells10113159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Y, Zhao W, Liu J, Chen Z, Lv Q, Zhang Z. Immunotherapy Summary for Cytokine Storm in COVID-19. Front Pharmacol 2021;12:731847. [PMID: 34603047 DOI: 10.3389/fphar.2021.731847] [Reference Citation Analysis]
4 Hulme KD, Noye EC, Short KR, Labzin LI. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections. Front Immunol 2021;12:770066. [PMID: 34777390 DOI: 10.3389/fimmu.2021.770066] [Reference Citation Analysis]
5 Tran BM, Grimley SL, McAuley JL, Hachani A, Earnest L, Wong SL, Caly L, Druce J, Purcell DFJ, Jackson DC, Catton M, Nowell CJ, Leonie L, Deliyannis G, Waters SA, Torresi J, Vincan E. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection. Int J Mol Sci 2022;23:835. [PMID: 35055020 DOI: 10.3390/ijms23020835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Long Q, Li J, Hu X, Bai Y, Zheng Y, Gao Z. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:702635. [PMID: 34540862 DOI: 10.3389/fmed.2021.702635] [Reference Citation Analysis]
7 Osan J, Talukdar SN, Feldmann F, Demontigny BA, Jerome K, Bailey KL, Feldmann H, Mehedi M, I. Parra G. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease. Microbiol Spectr. [DOI: 10.1128/spectrum.00459-22] [Reference Citation Analysis]
8 Grebennikov D, Kholodareva E, Sazonov I, Karsonova A, Meyerhans A, Bocharov G. Intracellular Life Cycle Kinetics of SARS-CoV-2 Predicted Using Mathematical Modelling. Viruses 2021;13:1735. [PMID: 34578317 DOI: 10.3390/v13091735] [Reference Citation Analysis]
9 Malavige GN, Jeewandara C, Ogg GS. Dengue and COVID-19: two sides of the same coin. J Biomed Sci 2022;29:48. [PMID: 35786403 DOI: 10.1186/s12929-022-00833-y] [Reference Citation Analysis]
10 Kim DY, Shinde SK, Lone S, Palem RR, Ghodake GS. COVID-19 Pandemic: Public Health Risk Assessment and Risk Mitigation Strategies. J Pers Med 2021;11:1243. [PMID: 34945715 DOI: 10.3390/jpm11121243] [Reference Citation Analysis]
11 Kovacs-Kasa A, Zaied AA, Leanhart S, Koseoglu M, Sridhar S, Lucas R, Fulton DJ, Vazquez JA, Annex BH. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability. Microbiol Spectr 2022;:e0167121. [PMID: 35171047 DOI: 10.1128/spectrum.01671-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shams S, Azari-Yam A, Safavi M, Zamani Z, Sotoudeh-Anvari M, Sharifzadeh Ekbatani M, Haghi-Ashtiani MT, Mozafari F, Yaghmaie B, Shafeghat L. Alteration of Plasma Amino Acid Concentrations in Iranian Children with COVID-19. Int J Pediatr 2022;2022:9390327. [PMID: 35915604 DOI: 10.1155/2022/9390327] [Reference Citation Analysis]
13 Giraldo-Ramirez S, Rendon-Marin S, Jaimes JA, Martinez-Gutierrez M, Ruiz-Saenz J. SARS-CoV-2 Clinical Outcome in Domestic and Wild Cats: A Systematic Review. Animals (Basel) 2021;11:2056. [PMID: 34359182 DOI: 10.3390/ani11072056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Szabo M, Sarkozy D, Szigeti M, Farsang R, Kardos Z, Kozma A, Csanky E, Chung DS, Szekanecz Z, Guttman A. Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product. Front Bioeng Biotechnol 2022;10:839374. [DOI: 10.3389/fbioe.2022.839374] [Reference Citation Analysis]
15 Du L, Yang Y, Zhang X. Neutralizing antibodies for the prevention and treatment of COVID-19. Cell Mol Immunol 2021;18:2293-306. [PMID: 34497376 DOI: 10.1038/s41423-021-00752-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mignani S, Shi X, Karpus A, Lentini G, Majoral JP. Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity. Pharmaceutics 2021;13:1513. [PMID: 34575589 DOI: 10.3390/pharmaceutics13091513] [Reference Citation Analysis]
17 Nyaruaba R, Mwaliko C, Dobnik D, Neužil P, Amoth P, Mwau M, Yu J, Yang H, Wei H. Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks. Clin Microbiol Rev 2022;:e0016821. [PMID: 35258315 DOI: 10.1128/cmr.00168-21] [Reference Citation Analysis]
18 Chekol Abebe E, Mengie Ayele T, Tilahun Muche Z, Asmamaw Dejenie T. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target. Biologics 2021;15:143-52. [PMID: 33986591 DOI: 10.2147/BTT.S307352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Quispe-Coica A, Pérez-Foguet A. A new measure of hygiene inequality applied to urban-rural comparison. Int J Hyg Environ Health 2022;239:113876. [PMID: 34757280 DOI: 10.1016/j.ijheh.2021.113876] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]
21 Bussolari C, Palumbo D, Fominsky E, Nardelli P, De Lorenzo R, Vitali G, De Cobelli F, Rovere-Querini P, Scandroglio AM. Case Report: Nintedaninb May Accelerate Lung Recovery in Critical Coronavirus Disease 2019. Front Med (Lausanne) 2021;8:766486. [PMID: 34778326 DOI: 10.3389/fmed.2021.766486] [Reference Citation Analysis]
22 Mohammad KO, Rodriguez JBC, Urey MA. Coronavirus disease 2019 and the cardiologist. Curr Opin Cardiol 2022;37:335-42. [PMID: 35731679 DOI: 10.1097/HCO.0000000000000958] [Reference Citation Analysis]
23 Radvak P, Kwon HJ, Kosikova M, Ortega-Rodriguez U, Xiang R, Phue JN, Shen RF, Rozzelle J, Kapoor N, Rabara T, Fairman J, Xie H. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains. Nat Commun 2021;12:6559. [PMID: 34772941 DOI: 10.1038/s41467-021-26803-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 He Y, Qi J, Xiao L, Shen L, Yu W, Hu T. Purification and characterization of the receptor-binding domain of SARS-CoV-2 spike protein from Escherichia coli. Eng Life Sci 2021;21:453-60. [PMID: 34140855 DOI: 10.1002/elsc.202000106] [Reference Citation Analysis]
25 Han H, Wang C, Yang X, Zheng S, Cheng X, Liu Z, Zhao B, Xiao R. Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor. Sens Actuators B Chem 2022;351:130897. [PMID: 34658530 DOI: 10.1016/j.snb.2021.130897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Schreiber A, Viemann D, Schöning J, Schloer S, Mecate Zambrano A, Brunotte L, Faist A, Schöfbänker M, Hrincius E, Hoffmann H, Hoffmann M, Pöhlmann S, Rescher U, Planz O, Ludwig S. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses. Cell Mol Life Sci 2022;79:65. [PMID: 35013790 DOI: 10.1007/s00018-021-04085-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Saratale GD, Shin H, Shinde SK, Kim D, Saratale RG, Kadam AA, Kumar M, Bahkali AH, Syed A, Ghodake GS. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. JPM 2022;12:349. [DOI: 10.3390/jpm12030349] [Reference Citation Analysis]
28 Carmona-Torre F, Mínguez-Olaondo A, López-Bravo A, Tijero B, Grozeva V, Walcker M, Azkune-Galparsoro H, López de Munain A, Alcaide AB, Quiroga J, Del Pozo JL, Gómez-Esteban JC. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies. Front Neurol 2022;13:886609. [PMID: 35720084 DOI: 10.3389/fneur.2022.886609] [Reference Citation Analysis]
29 Suprewicz Ł, Swoger M, Gupta S, Piktel E, Byfield FJ, Iwamoto DV, Germann D, Reszeć J, Marcińczyk N, Carroll RJ, Janmey PA, Schwarz JM, Bucki R, Patteson AE. Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion. Small 2021;:e2105640. [PMID: 34866333 DOI: 10.1002/smll.202105640] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zhang Y, Li Z, Milon Essola J, Ge K, Dai X, He H, Xiao H, Weng Y, Huang Y. Biosafety materials: ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Zerbato V, Di Bella S, Giuffrè M, Jaracz AW, Gobbo Y, Luppino D, Macor P, Segat L, Koncan R, D'Agaro P, Valentini M, Crocé LS, Ruscio M, Luzzati R. High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study. World J Gastroenterol 2021; 27(22): 3130-3137 [PMID: 34168414 DOI: 10.3748/wjg.v27.i22.3130] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
32 Sun J, Liu Q, Zhang X, Dun S, Liu L. Mitochondrial hijacking: a potential mechanism for SARS-CoV-2 to impair female fertility. Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110778] [Reference Citation Analysis]
33 Kianpour M, Akbarian M, Uversky VN. Nanoparticles for Coronavirus Control. Nanomaterials (Basel) 2022;12:1602. [PMID: 35564311 DOI: 10.3390/nano12091602] [Reference Citation Analysis]
34 Xiang M, Jing H, Wang C, Novakovic VA, Shi J. Persistent Lung Injury and Prothrombotic State in Long COVID. Front Immunol 2022;13:862522. [PMID: 35464473 DOI: 10.3389/fimmu.2022.862522] [Reference Citation Analysis]
35 Serebrennikova KV, Byzova NA, Zherdev AV, Khlebtsov NG, Khlebtsov BN, Biketov SF, Dzantiev BB. Lateral Flow Immunoassay of SARS-CoV-2 Antigen with SERS-Based Registration: Development and Comparison with Traditional Immunoassays. Biosensors (Basel) 2021;11:510. [PMID: 34940267 DOI: 10.3390/bios11120510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Teixeira AL, Krause TM, Ghosh L, Shahani L, Machado-Vieira R, Lane SD, Boerwinkle E, Soares JC. Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020. JAMA Netw Open 2021;4:e2134969. [PMID: 34812848 DOI: 10.1001/jamanetworkopen.2021.34969] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wang Y, Wang X, Li Y, Xue Z, Shao R, Li L, Zhu Y, Zhang H, Yang J. Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway. Pharmacol Res 2022;176:106083. [PMID: 35033647 DOI: 10.1016/j.phrs.2022.106083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ma C, Tu D, Gu J, Xu Q, Hou P, Wu H, Guo Z, Bai Y, Zhao X, Li P. The Predictive Value of Myoglobin for COVID-19-Related Adverse Outcomes: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:757799. [PMID: 34869669 DOI: 10.3389/fcvm.2021.757799] [Reference Citation Analysis]
39 Zhang M, Liang Y, Yu D, Du B, Cheng W, Li L, Yu Z, Luo S, Zhang Y, Wang H, Zhang X, Zhang W. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant. Int J Biol Sci 2022;18:889-900. [PMID: 35002532 DOI: 10.7150/ijbs.68973] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
40 Oliva R, Mukherjee S, Manisegaran M, Campanile M, Del Vecchio P, Petraccone L, Winter R. Binding Properties of RNA Quadruplex of SARS-CoV-2 to Berberine Compared to Telomeric DNA Quadruplex. Int J Mol Sci 2022;23:5690. [PMID: 35628500 DOI: 10.3390/ijms23105690] [Reference Citation Analysis]
41 Tews H, Kandulski A, Schmid S, Peschel G, Gülow K, Schlosser S, Schirner S, Stroszczynski C, Müller M, Jung E. Contrast enhanced ultrasonography (CEUS) a novel tool to detect intestinal epithelial barrier dysfunction in severe COVID-19 disease. CH 2022. [DOI: 10.3233/ch-221407] [Reference Citation Analysis]
42 Khwatenge CN, Pate M, Miller LC, Sang Y. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19. Front Immunol 2021;12:732913. [PMID: 34737743 DOI: 10.3389/fimmu.2021.732913] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Nam M, Seo JD, Moon HW, Kim H, Hur M, Yun YM. Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay. Microbiol Spectr 2021;9:e0120221. [PMID: 34817223 DOI: 10.1128/Spectrum.01202-21] [Reference Citation Analysis]
44 Pang B, Li H, Liu Q, Wu P, Xia T, Zhang X, Le W, Li J, Lai L, Ou C, Ma J, Liu S, Zhou F, Wang X, Xie J, Zhang Q, Jiang M, Liu Y, Zeng Q. CT Quantification of COVID-19 Pneumonia at Admission Can Predict Progression to Critical Illness: A Retrospective Multicenter Cohort Study. Front Med (Lausanne) 2021;8:689568. [PMID: 34222293 DOI: 10.3389/fmed.2021.689568] [Reference Citation Analysis]
45 Bhowal P, Sen S, Sarkar R. A two-tier feature selection method using Coalition game and Nystrom sampling for screening COVID-19 from chest X-Ray images. J Ambient Intell Humaniz Comput 2021;:1-16. [PMID: 34567278 DOI: 10.1007/s12652-021-03491-4] [Reference Citation Analysis]
46 Chen ZR, Liu J, Liao ZG, Zhou J, Peng HW, Gong F, Hu JF, Zhou Y. COVID-19 and gastroenteric manifestations . World J Clin Cases 2021; 9(19): 4990-4997 [PMID: 34307549 DOI: 10.12998/wjcc.v9.i19.4990] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
47 Cordeiro A, Ribamar A, Ramalho A. ADIPOSE TISSUE DYSFUNCTION AND MAFLD IN OBESITY ON THE SCENE OF COVID-19. Clin Res Hepatol Gastroenterol 2021;:101807. [PMID: 34543756 DOI: 10.1016/j.clinre.2021.101807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Alsobaie S. Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review. Infect Drug Resist 2021;14:2259-68. [PMID: 34163190 DOI: 10.2147/IDR.S306441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Pelizzari L, Cazzoli M, Lipari S, Laganà MM, Cabinio M, Isernia S, Pirastru A, Clerici M, Baglio F. Mid-term MRI evaluation reveals microstructural white matter alterations in COVID-19 fully recovered subjects with anosmia presentation. Ther Adv Neurol Disord 2022;15:17562864221111995. [PMID: 35899101 DOI: 10.1177/17562864221111995] [Reference Citation Analysis]
50 Zhang Y, Almazi JG, Ong HX, Johansen MD, Ledger S, Traini D, Hansbro PM, Kelleher AD, Ahlenstiel CL. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. Int J Mol Sci 2022;23:2408. [PMID: 35269550 DOI: 10.3390/ijms23052408] [Reference Citation Analysis]
51 Li BH, Li ZY, Liu MM, Tian JZ, Cui QH. Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review. Front Pharmacol 2021;12:743623. [PMID: 34531754 DOI: 10.3389/fphar.2021.743623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Ortega-Paredes D, Larrea-Álvarez CM, Jijón SI, Loaiza K, Šefcová MA, Molina-Cuasapaz G, Barba P, Vinueza-Burgos C, Fernandez-Moreira E, Ramírez H, Larrea-Álvarez M. A Cross-Sectional Study to Assess Knowledge of COVID-19 among Undergraduate Students in North-Central Ecuador. Int J Environ Res Public Health 2021;18:8706. [PMID: 34444455 DOI: 10.3390/ijerph18168706] [Reference Citation Analysis]
53 Hirano J, Murakami K, Hayashi T. CRISPR-Cas9-Based Technology for Studying Enteric Virus Infection. Front Genome Ed 2022;4:888878. [DOI: 10.3389/fgeed.2022.888878] [Reference Citation Analysis]
54 Muderris T, Aysel A, Yiş R, Muderris T, Öktem İMA, Çorakçı O. Is adenotonsillectomy safe in covid-19 era? Investigation of sars-cov2 in adenoid and tonsil tissues. Am J Otolaryngol 2022;43:103458. [PMID: 35413545 DOI: 10.1016/j.amjoto.2022.103458] [Reference Citation Analysis]
55 Szlachcic WJ, Dabrowska A, Milewska A, Ziojla N, Blaszczyk K, Barreto-Duran E, Sanak M, Surmiak M, Owczarek K, Grzanka D, Durzynska J, Pyrc K, Borowiak M. SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis. iScience 2022;:104594. [PMID: 35756892 DOI: 10.1016/j.isci.2022.104594] [Reference Citation Analysis]